Kurt C. Demel

Assistant professor
Hematology, Oncology and Transplantation
HealthPartners Research Foundation
United States of America

Professor Haematology

Biography

Kurt C. Demel is a Assistant professor, Department of Hematology, Oncology and Transplantation, University of Minnesota.he had Completed his MD, University of Cincinnati; residency in internal medicine, Christ Hospital, Cincinnati; fellowship in hematology and oncology, Brown University, Providence, RI. Dr. Demel has been recognized by the National Cancer Institute for his commitment to clinical research.Dr. Demel is an investigator in several National Cancer Institute-sponsored trials through the Metro-Minnesota Community Oncology Research Consortium and pharmaceutical companies.

Research Intrest

special interests include head and neck cancer and benign/malignant hematology. He is also very interested in the emotional, spiritual and physical aspects of cancer survivorship.

List of Publications

Glasser L, Meloni-Ehrig A, Greaves W, Demel KC, Butera J (2009) Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation. Transfusion. 49(3):555-62.

Barnett JM, Demel KC, Mega AE, Butera JN, Sweeney JD (2005) Lack of bleeding in patients with severe factor VII deficiency. Am J Hematol. 78(2):134-7.

Reusch U, Sundaram M, Davol PA, Olson SD, Davis JB, et al., (2006) Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.Clin Cancer Res. 12(1):183-90.

Find Experts

Experts in Haematology

Kurt C. Demel

Glasser L, Meloni-Ehrig A, Greaves W, Demel KC, Butera J (2009) Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation. Transfusion. 49(3):555-62.

Barnett JM, Demel KC, Mega AE, Butera JN, Sweeney JD (2005) Lack of bleeding in patients with severe factor VII deficiency. Am J Hematol. 78(2):134-7.

Reusch U, Sundaram M, Davol PA, Olson SD, Davis JB, et al., (2006) Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.Clin Cancer Res. 12(1):183-90.

Experts in United States of America

Connect with your Global Scientific Fields by Subject